A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial). (Q36868708)
Jump to navigation
Jump to search
scientific article published on 8 July 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial). |
scientific article published on 8 July 2008 |
Statements
1 reference
A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial). (English)
1 reference
Jan Walewski
1 reference
Graham M Mead
1 reference
Sharon L Barrans
1 reference
Wendi Qian
1 reference
John A Radford
1 reference
Max Wolf
1 reference
Simon M Clawson
1 reference
Sally P Stenning
1 reference
Claire L Yule
1 reference
Andrew S Jack
1 reference
UK National Cancer Research Institute Lymphoma Clinical Studies Group
1 reference
Australasian Leukaemia and Lymphoma Group
1 reference
8 July 2008
1 reference
1 reference
2248-2260
1 reference
2 references
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference